Cargando…

RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions

Oligomerization and aggregation of misfolded forms of α-synuclein are believed to be key molecular mechanisms in Parkinson’s disease (PD) and other synucleinopathies, so extensive research has attempted to understand these processes. Among diverse post-translational modifications that impact α-synuc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gelain, Daniel Pens, Bittencourt, Reykla Ramon, Bastos Mendes, Luiz Filipe, Moreira, José Claudio Fonseca, Outeiro, Tiago Fleming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Basic Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473104/ https://www.ncbi.nlm.nih.gov/pubmed/37270812 http://dx.doi.org/10.3233/JPD-230070

Ejemplares similares

Drug Targeting of α-Synuclein Oligomerization in Synucleinopathies
por: Outeiro, Tiago Fleming, et al.
Publicado: (2008)

Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA–induced dopaminergic denervation
por: Gasparotto, Juciano, et al.
Publicado: (2017)

More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy
por: Flores-Leon, Manuel, et al.
Publicado: (2023)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
por: Brás, Inês C., et al.
Publicado: (2021)

Glycation in Huntington’s Disease: A Possible Modifier and Target for Intervention
por: Brás, Inês Caldeira, et al.
Publicado: (2019)

Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson’s Disease
por: König, Annekatrin, et al.
Publicado: (2018)

Intranasal HSP70 administration protects against dopaminergic denervation and modulates neuroinflammatory response in the 6-OHDA rat model
por: Tiefensee Ribeiro, Camila, et al.
Publicado: (2021)

Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy
por: Badiola, Nahuai, et al.
Publicado: (2011)

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
por: Sparvero, Louis J, et al.
Publicado: (2009)

miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy
por: Xylaki, Mary, et al.
Publicado: (2023)

A Novel Microfluidic Cell Co-culture Platform for the Study of the Molecular Mechanisms of Parkinson's Disease and Other Synucleinopathies
por: Fernandes, João T. S., et al.
Publicado: (2016)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

The role of receptor for advanced glycation endproducts (RAGE) in infection
por: van Zoelen , Marieke AD, et al.
Publicado: (2011)

The Role of Receptor for Advanced Glycation Endproducts (RAGE) in Infection
por: van Zoelen, M. A. D., et al.
Publicado: (2011)

Development of the facial glycation imaging system for in situ human face skin glycation index measurement
por: Lee, Jinyong, et al.
Publicado: (2021)

Soluble Forms of the Receptor for Advanced Glycation Endproducts (RAGE) in Periodontitis
por: Detzen, Laurent, et al.
Publicado: (2019)

The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling
por: Reed, James C., et al.
Publicado: (2020)

Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
por: Drake, Lindsey R., et al.
Publicado: (2020)

Glycation potentiates neurodegeneration in models of Huntington’s disease
por: Vicente Miranda, Hugo, et al.
Publicado: (2016)

Reverse Engineering the Neuroblastoma Regulatory Network Uncovers MAX as One of the Master Regulators of Tumor Progression
por: Albanus, Ricardo D’Oliveira, et al.
Publicado: (2013)

Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice
por: McVicar, Carmel M., et al.
Publicado: (2015)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
por: González-Guerrero, Diana Elizabeth, et al.
Publicado: (2023)

RAGE, Receptor of Advanced Glycation Endoproducts, Negatively Regulates Chondrocytes Differentiation
por: Kosaka, Tatsuya, et al.
Publicado: (2014)

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
por: Taneja, Sakshi, et al.
Publicado: (2021)

Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients
por: Lazzari, Tássia Kirchmann, et al.
Publicado: (2021)

The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases
por: Delrue, Charlotte, et al.
Publicado: (2023)

Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
por: Yao, Dachun, et al.
Publicado: (2010)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
por: Caldiroli, Lara, et al.
Publicado: (2022)

Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition
por: Farzadfard, Azad, et al.
Publicado: (2022)

ATP13A2 and Alpha-synuclein: a Metal Taste in Autophagy
por: Lopes da Fonseca, Tomás, et al.
Publicado: (2014)

The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma
por: Yaser, Al-Madhagi, et al.
Publicado: (2012)

Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity
por: Teismann, Peter, et al.
Publicado: (2012)

The Receptor for Advanced Glycation End Products (RAGE) Contributes to the Progression of Emphysema in Mice
por: Sambamurthy, Nisha, et al.
Publicado: (2015)

The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation
por: Lancefield, Terase F., et al.
Publicado: (2016)

Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
por: Bongarzone, Salvatore, et al.
Publicado: (2017)

Receptor for advanced glycation end-products (RAGE) mediates phagocytosis in nonprofessional phagocytes
por: Yang, Yan, et al.
Publicado: (2022)

Receptor for the Advanced Glycation End Products (RAGE) Pathway in Adipose Tissue Metabolism
por: Gutowska, Klaudia, et al.
Publicado: (2023)

Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases
por: Lee, Eun Ji, et al.
Publicado: (2013)

SUN-LB131 Association of Receptor for Advanced Glycation End Product (RAGE) Gene Polymorphisms & Serum Levels of Soluble RAGE (sRAGE) With Metabolic Syndrome (MS) in Mexican Population
por: Gonzalez-Guerrero, Diana Elizabeth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cg12epfrun4l09qbk65l2rrbqk